🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors promote the substance there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users administering substances of unknown origin.

Some professionals said the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or distributed for human use under the British medical regulations.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Platform Response and Content Removal

Based on TikTok, the platform has taken down problematic content and prohibited associated hashtags and query recommendations. The organization said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also discovered communities with up to nine thousand participants selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with numerous of users, filled with images of weight loss, glowing testimonials and detailed instructions for mixing or administering at home.

Within moments of entering one community, a vendor posted WhatsApp details, where most transactions occur. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Costs

Inside these groups, messages display dark colored parcels with Royal Mail labels, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it actively monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has previously encountered individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to potentially significant medical dangers”.